Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $5.06 million as of January 31, 2025. Its market cap has increased by 10.22% in one year.

Market Cap

5.06M

Enterprise Value

56.67M

Revenue

44.89M

Ranking

n/a

PE Ratio

1.04

Stock Price

$1.15

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 5.06M, a decrease of -97.72%. That is a compound annual growth rate of -13.19%.

Market Cap History

Date	Market Cap	% Change
Jan 31, 2025	5.06M	-57.37%
Dec 31, 2024	11.87M	152.98%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	12.69M	-33.55%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.13B
SS Innovations International	1.55B
Veradigm	1.29B
Nika Pharmaceuticals	1.02B
Elite Pharmaceuticals	500.05M
Glass House Brands	469.08M
Northwest Biotherapeutics	377.51M
CytoDyn	255.23M

Market Cap Rankings